Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 4Phase 4 1Phase 3 1Phase 1 1

Status

Unknown 2Recruiting 1Completed 1

Sponsor Class

OTHER 57OTHER_GOV 4INDUSTRY 3

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 196Breast 126Gynecologic 75Genitourinary 53Head & Neck 48Thoracic 37CNS 32Lymphoid 30Tumor-Agnostic 27Other hematologic neoplasm 27Sarcoma 11Endocrine 11Dermatologic 10Other 9Plasma cell 8Other solid neoplasm 6Myeloid 5NET 4Classical hematology 2Other neoplasm 1

Conditions

Neuroendocrine Tumors 4

Interventions

copper dotatate CU-64 1Lutetium-177 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × OTHER_GOV × NET × Clear all
NCT07536087 2026-04-17

Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Pancreatic Neuroendocrine Tumors

Institute for Clinical and Experimental Medicine

Phase NA Recruiting
50 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT02125474 2019-11-14

Efficacy of 177-Lu-DOTA 0, Tyr 3 Octreotate

Instituto Nacional de Cancerologia, Columbia

Phase NA Completed
39 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT04152928 2019-11-06

Applying PET/MR in Neuroendocrine Tumors - Imaging Dynamic Processes in Both Modalities

Tel-Aviv Sourasky Medical Center

Phase NA Unknown
50 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT04154241 2019-11-06

Developing a Method Using PET-MR to Improve Staging and Monitoring of Neuroendocrine Tumor

Tel-Aviv Sourasky Medical Center

Phase NA Unknown
50 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡